Pharma / Biotech Samples
Pharmaceutical Manufacturer Financial Analytics
Partnered with the CFO of a global pharmaceutical manufacturer to develop advanced financial account analytics and forecasting tools. Identified over $50M in financial adjustments and developed scalable data models to accommodate changes to product portfolio and business strategies.
Pharmaceutical Manufacturer M&A Assessment & Integration
Provided pre and post-acquisition M&A analyses to a global pharmaceutical manufacturer. Assisted in the evaluation of risk associated with systems transition, resource integration, compliance harmonization, and regulatory disclosures.
Biotech Profitability Assessment & Financial Transformation
For a leading biotechnology manufacturer, performed assessment of gross-to-net profitability of existing product portfolio and developed various financial models to forecast short, medium, and long term profitability in a variety of scenarios based on key variables (e.g. market growth, share growth, exclusivity duration, competitor entrants, regulatory changes).
Pharmaceutical Commercial Contracting & Pricing Systems
For a large pharmaceutical manufacturer, led assessment of current IT capabilities to support commercial contracting and product pricing requirements. Managed cross-functional team through the development of a business case for software solutions. Led functional requirements, vendor assessment, gap analysis, contract negotiation, requirements definition, implementation planning, user acceptance testing, launch, and post-launch support phases for a company-wide software solution implementation.
Pharmaceutical Product Launch and Pricing Strategy
Engaged by an early-stage pharmaceutical manufacturer to model pre-launch product pricing strategies, develop contracts compliance controls, and evaluate 3rd-party software/services vendor capabilities/scalability. Identified several risk areas, developed near and long-term mitigation plans, and led immediate remediation initiatives.
LBO/M&A Due Diligence
Led financial modeling and due diligence processes to support potential leveraged buyout of two manufacturing companies. Assessed potential synergies and challenges associated with the integration of financial, operational, IT, and compliance functions. Facilitated discussion between financial sponsors, operations teams, and lenders to identify initial deal terms and deal planning.